INTERNATIONAL PATENT: INMAGENE BIOPHARMACEUTICALS (HANGZHOU) CO., LTD., INMAGENE PTE. LTD. FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITIONS COMPRISING OX40 TARGETING ANTIBODIES AND USES THEREOF"

GENEVA, Sept. 15 -- INMAGENE BIOPHARMACEUTICALS (HANGZHOU) CO., LTD. (2F Building 9, Hexiang Science And Technology Center, Xiasha Road, Qiantang New AreaHangzhou, Zhejiang 310018), INMAGENE PTE. LTD. (20 Emerald Hill Road229302) filed a patent application (PCT/CN2025/080184) for "PHARMACEUTICAL COMPOSITIONS COMPRISING OX40 TARGETING ANTIBODIES AND USES THEREOF" on Mar 03, 2025. With publication no. WO/2025/185555, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUN, Qiang (2F Building 9, Hexiang Science And Technology Ce...